American International Group Inc. Lowers Stock Position in Humana Inc. (NYSE:HUM)

American International Group Inc. cut its holdings in Humana Inc. (NYSE:HUMFree Report) by 2.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,836 shares of the insurance provider’s stock after selling 1,040 shares during the period. American International Group Inc.’s holdings in Humana were worth $17,780,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Dorsey & Whitney Trust CO LLC lifted its holdings in Humana by 2.6% in the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock worth $397,000 after purchasing an additional 21 shares in the last quarter. First Financial Corp IN increased its stake in Humana by 7.2% in the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after acquiring an additional 23 shares during the last quarter. Walker Financial Services Inc. increased its stake in Humana by 3.9% in the 4th quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock worth $364,000 after acquiring an additional 30 shares during the last quarter. Signaturefd LLC increased its stake in Humana by 1.2% in the 4th quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock worth $1,206,000 after acquiring an additional 30 shares during the last quarter. Finally, Brighton Jones LLC increased its stake in Humana by 6.8% in the 4th quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock worth $215,000 after acquiring an additional 30 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on HUM. Jefferies Financial Group cut their target price on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Royal Bank of Canada cut their target price on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Baird R W raised Humana to a “hold” rating in a research report on Thursday, May 30th. Barclays cut their target price on Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Finally, UBS Group cut their price objective on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Thirteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $423.63.

View Our Latest Stock Analysis on HUM

Humana Stock Up 0.1 %

Shares of HUM stock traded up $0.48 during mid-day trading on Wednesday, hitting $361.35. The stock had a trading volume of 1,275,212 shares, compared to its average volume of 1,904,287. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The firm has a market capitalization of $43.54 billion, a P/E ratio of 22.50, a price-to-earnings-growth ratio of 2.14 and a beta of 0.53. Humana Inc. has a 12-month low of $298.61 and a 12-month high of $530.54. The firm’s 50-day moving average is $331.15 and its two-hundred day moving average is $364.29.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. During the same period in the prior year, the business posted $9.38 EPS. On average, analysts predict that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 22.04%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.